Neovantage Innovation Parks is proud to be an Industry Co Host at BioAsia 2026, Asia’s premier life sciences and health tech conference. BioAsia brings together global leaders, innovators, investors and policymakers to shape the future of healthcare and life sciences. Learn more about the event
Meet Our Delegates at BioAsia 2026
17 and 18 February 2026 | Booth S12
Atul Bhardwaj, Business Head
Arvind Ravella, Vice President
Manisha Jha, Senior Manager
For meetings and business enquiries
Contact: Manisha Jha - manisha.jha@lighthouse canton.com
This year’s theme TechBio Unleashed AI Automation and the Biology Revolution captures a defining shift in how science is being done. AI is compressing drug discovery timelines from years to months. Automation is transforming laboratory operations from high throughput screening to robotic sample handling. As computational workloads grow alongside traditional wet lab research, the infrastructure supporting science must evolve. Buildings today need to be flexible enough to adapt to changing tenant needs, robust enough to support increasing power and cooling demands, and sustainable enough to meet growing ESG expectations.
As South Asia’s largest private life sciences real estate platform, Neovantage is at the centre of this shift. Located in Genome Valley Hyderabad India’s largest life sciences cluster, Neovantage operates a portfolio of 1.4 million sq ft across 12 buildings, with 95 percent plus occupancy and 40 plus tenants. Our tenants include global pharmaceutical companies, biotechs, CDMOs and research organisations.
.jpg)
We are also expanding, with Building 4500 Phase 2 with 164,000 sq ft and Building 3600 Extension Annexe with 80,000 sq ft currently under construction, both scheduled for completion in Q4 2026. We look forward to presenting these upcoming developments at the event.
We offer purpose built laboratory and R and D facilities, build to suit developments, and multi tenanted innovation spaces for companies looking to scale. Our buildings are LEED Gold and LEED Platinum certified, and we are GRESB rated, reflecting our commitment to sustainable infrastructure and operational excellence.
As global organisations look to diversify their research footprints, India presents a compelling destination driven by scientific talent, cost efficiency and a maturing regulatory environment. BioAsia 2026 is where these conversations will take shape. As Industry Co Host, Neovantage looks forward to engaging with pharmaceutical and biotech leaders exploring India’s life sciences ecosystem.
Our team will be available throughout the event. Reach out to explore how Neovantage can support your growth in India.
We look forward to seeing you!
%20(2).png)


.png)
.png)
.png)


.png)

.png)


